Literature DB >> 26691743

Integrated multidisciplinary community service for chronic obstructive pulmonary disease reduces hospitalisations.

L P Chung1, F Lake2,3, E Hyde1, C McCamley4, N Phuangmalai1, M Lim1, G Waterer1,5, Q Summers1, Y Moodley1,5.   

Abstract

BACKGROUND: Hospitalisations for chronic obstructive pulmonary disease (COPD) exacerbation affect patient outcomes and healthcare costs. The long-term impact of an integrated COPD disease-management approach on hospitalisation remains controversial. AIM: The aim of this study was to evaluate whether a multidisciplinary community service reduces respiratory hospitalisations for COPD patients.
METHODS: A total of 346 patients was followed for a mean duration of 27.3 months. The number of admissions, total bed days for respiratory (COPD exacerbation or pneumonia) or general medical causes and length of stay (LOS) per respiratory admission was compared before and after referral with the service. A secondary multivariate analysis examined which clinical parameters best predict benefit from such service.
RESULTS: The total respiratory admission and hospital bed days after referral were reduced by 31% (288 vs 417, P < 0.001) and 40.4% (1637 vs 2746, P < 0.0001) respectively, compared with the equivalent duration prior. The average LOS for each respiratory admission was also significantly reduced after referral (6.61 vs 5.70, P = 0.02). Overall, 55% patients experienced a reduction in admission frequency and hospital days. The impact on admission frequency and hospital days was the greatest in those with an at least moderate disease (GOLD ≥2, odds ratio (OR): 3.2, 95% confidence interval (CI): 1.2, 8.9; P = 0.019) and those who completed pulmonary rehabilitation (PR) (OR: 1.7, 95% CI: 1.1, 2.8; P = 0.04). In contrast, general medical admissions increased, one-third attributable to a cardiovascular cause both before and after referral.
CONCLUSIONS: The implementation of COPD multidisciplinary community service was associated with reduced respiratory hospitalisations in the long term. Patients with moderate or severe disease and who are able to complete PR are much more likely to benefit.
© 2016 Royal Australasian College of Physicians.

Entities:  

Keywords:  COPD; community; exacerbations; hospitalisations; multidisciplinary; pneumonia

Mesh:

Year:  2016        PMID: 26691743     DOI: 10.1111/imj.12984

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  1 in total

1.  Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis.

Authors:  Jilles M Fermont; Katya L Masconi; Magnus T Jensen; Renata Ferrari; Valéria A P Di Lorenzo; Jacob M Marott; Philipp Schuetz; Henrik Watz; Benjamin Waschki; Hana Müllerova; Michael I Polkey; Ian B Wilkinson; Angela M Wood
Journal:  Thorax       Date:  2019-01-07       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.